What We Do

Our community based and grass-root oriented activities revolves around;

Advocacy and Awareness creation on viral hepatitis among high risk and most susceptible groups in Nigeria.

Conducting population based research activities focused on primary prevention of viral hepatitis in the six geopolitical zones of Nigeria.

Support in the care and management of patients with viral hepatitis and people living with complications of viral hepatitis.

Our MISSION is to heighten the awareness, prevention, screening and diagnosis
of viral hepatitis in Nigeria as well as facilitate access to treatment and prevent
complications of viral hepatitis. This is to be achieved through planning and
implementation of strategic advocacy, research and interventional
programmes in the different regions of the country.
Our VISION is to have a Nigerian nation free from viral hepatitis and its complications.

Our Numbers

0
Volunteers

We are a dedicated and committed team.

Join Volunteers
0
Events

Planned events for 2022 and beyond with active impacts on the society.

View Events
0
Million

20 million people have chronic hepatitis in Nigeria (WHO, 2018)

Donate To Help

Our Research

Patterns of hepatitis b virus immune escape and pol/rt mutations across clinical cohorts of patients with genotypes a, e and occult hepatitis b infection in Nigeria: A multi-centre study.

Patterns of hepatitis b virus immune escape and pol/rt mutations across clinical cohorts of patients with genotypes a, e and occult hepatitis b infection in Nigeria: A multi-centre study.

Abstract: Hepatitis B virus (HBV) immune escape and Pol/RT mutations account for HBV immunoprophylactic, therapeutic, and diagnostic failure...

Learn more
Non-Invasive assessment of hepatic fibrosis among patients with chronic Hepatitis B virus infection in Nigeria.

Non-Invasive assessment of hepatic fibrosis among patients with chronic Hepatitis B virus infection in Nigeria.

Study Background: Chronic hepatitis B virus (HBV) infection is a major cause of liver morbidity and mortality worldwide (Pyrsopoulos, 2021)...

Learn more
Patterns of SARSCoV2 Natural IgG Antibodies Among Asymptomatic HAART Experienced HIV/HBV/SARSCoV2 Tripple Viral Co-infected Patients in Nigeria.

Patterns of SARSCoV2 Natural IgG Antibodies Among Asymptomatic HAART Experienced HIV/HBV/SARSCoV2 Tripple Viral Co-infected Patients in Nigeria.

Abstract: Pathologic events in the early phase of SARSCoV2 infection involves perturbation of immune function with associated characteristic...

Learn more
More Research Articles

Our Blog

HEPATOCELLULAR CARCINOMA (HCC) / LIVER CANCER – WHAT YOU SHOULD KNOW
HEPATOCELLULAR CARCINOMA (HCC) / LIVER CANCER – WHAT YOU SHOULD KNOW

Hepatocellular Carcinoma (Liver cancer) is an abnormal uncontrollable growth of liver cells that is very fatal. It...

Learn More
HEPATITIS C VIRUS – WHAT IS THE TREATMENT
HEPATITIS C VIRUS – WHAT IS THE TREATMENT

Hepatitis C virus (HCV) is a single stranded RNA virus that causes Acute and Chronic viral hepatitis which if...

Learn More
All posts

Our Events

All events

Our Partners

The TaskForce for Global Health

Board of Trustees

These wonderful people make EIVH possible
Dr Lukman Abdulkareem
Dr Lukman Abdulkareem

Strategy, Advocacy and Planning Coordinator
Dr Ijeoma Ifeorah
Dr Ijeoma Ifeorah

Treasurer
Dr. Osasona Oluwadamilola Gideon
Dr. Osasona Oluwadamilola Gideon

Research Coordinator
Dr Olumuyiwa Ariyo
Dr Olumuyiwa Ariyo

Secretary
Mrs Philomena Eromon
Mrs Philomena Eromon

Vice Chairman

Donate Today to Help Eradicate Hepatitis From Nigeria